PL3065749T3 - Kompozycja farmaceutyczna zawierająca saccharomyces boulardii do redukcji tkanki tłuszczowej - Google Patents

Kompozycja farmaceutyczna zawierająca saccharomyces boulardii do redukcji tkanki tłuszczowej

Info

Publication number
PL3065749T3
PL3065749T3 PL14808522T PL14808522T PL3065749T3 PL 3065749 T3 PL3065749 T3 PL 3065749T3 PL 14808522 T PL14808522 T PL 14808522T PL 14808522 T PL14808522 T PL 14808522T PL 3065749 T3 PL3065749 T3 PL 3065749T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
body fat
reducing body
saccharomyces boulardii
boulardii
Prior art date
Application number
PL14808522T
Other languages
English (en)
Inventor
Patrice D. Cani
Amandine EVERARD
Lucie Geurts
Emilie Fargier
Marc Verleye
Marie-Emmanuelle Le Guern
Original Assignee
Biocodex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocodex filed Critical Biocodex
Publication of PL3065749T3 publication Critical patent/PL3065749T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL14808522T 2013-11-08 2014-11-07 Kompozycja farmaceutyczna zawierająca saccharomyces boulardii do redukcji tkanki tłuszczowej PL3065749T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20130306537 EP2870969A1 (fr) 2013-11-08 2013-11-08 Composition pharmaceutique pour la réduction de la masse adipeuse
PCT/EP2014/074109 WO2015067788A1 (fr) 2013-11-08 2014-11-07 Composition pharmaceutique pour la reduction de la masse adipeuse
EP14808522.8A EP3065749B1 (fr) 2013-11-08 2014-11-07 Composition pharmaceutique comprenant saccharomyces boulardii pour la reduction de la masse adipeuse

Publications (1)

Publication Number Publication Date
PL3065749T3 true PL3065749T3 (pl) 2021-01-25

Family

ID=49622767

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14808522T PL3065749T3 (pl) 2013-11-08 2014-11-07 Kompozycja farmaceutyczna zawierająca saccharomyces boulardii do redukcji tkanki tłuszczowej

Country Status (9)

Country Link
US (1) US20160287649A1 (pl)
EP (2) EP2870969A1 (pl)
CA (1) CA2929197C (pl)
DK (1) DK3065749T3 (pl)
ES (1) ES2821386T3 (pl)
LT (1) LT3065749T (pl)
PL (1) PL3065749T3 (pl)
PT (1) PT3065749T (pl)
WO (1) WO2015067788A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL3685681T3 (pl) * 2019-01-23 2024-10-21 Lesaffre Et Compagnie Produkt drożdżowy i zawierająca go kompozycja do zastosowania jako środek prebiotyczny

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0956867A1 (de) * 1998-05-12 1999-11-17 Franz-Peter Dr. Liebel Verwendung von Flavonoidglykosiden, Gerbstoffen und Mikroorganismen zur Therapie und Prophylaxe des Diabetes mellitus
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
FR2919187B1 (fr) * 2007-07-25 2009-11-27 Lesaffre & Cie Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie.
EP2030623A1 (en) * 2007-08-17 2009-03-04 Nestec S.A. Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria
EP2419115B1 (fr) * 2009-04-15 2014-12-31 Actigenomics S.A. Composition destinee a la regulation du metabolisme des lipides
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
WO2014046804A1 (en) * 2012-09-20 2014-03-27 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions

Also Published As

Publication number Publication date
US20160287649A1 (en) 2016-10-06
PT3065749T (pt) 2020-09-28
CA2929197C (fr) 2022-07-12
LT3065749T (lt) 2020-12-10
EP3065749B1 (fr) 2020-06-24
EP3065749A1 (fr) 2016-09-14
CA2929197A1 (fr) 2015-05-14
EP2870969A1 (fr) 2015-05-13
WO2015067788A1 (fr) 2015-05-14
ES2821386T3 (es) 2021-04-26
DK3065749T3 (da) 2020-09-28

Similar Documents

Publication Publication Date Title
IL288961A (en) Pharmaceutical preparations
PL3030262T3 (pl) Złożona kompozycja farmaceutyczna
SG10201912735TA (en) Pharmaceutical composition of s-ketamine hydrochloride
PL2943181T3 (pl) Kompozycje farmaceutyczne
SG10201802104QA (en) Pharmaceutical composition of s-ketamine hydrochloride
ZA201408333B (en) Pharmaceutical compositions
EP2970924A4 (en) PHYTASEFORMULIERUNG
PL2839750T3 (pl) Kompozycja tłuszczowa
SG11201509308TA (en) Low dose pharmaceutical composition
IL241175B (en) A pharmaceutical preparation for the treatment of fungal infections
PL2956010T5 (pl) Kompozycja tłuszczów
TWI562776B (en) Pharmaceutical composition and uses thereof
SG11201601477VA (en) Pharmaceutical composition
HUP1300496A2 (hu) Stabil kombinációs gyógyszerkészítmény
IL244365A0 (en) pharmaceutical preparation
LT3065749T (lt) Farmacinė kompozicija, apimanti saccharomyces boulardii kūno riebalų mažinimui
AP2015008890A0 (en) Pharmaceutical compositions
SG11201505590TA (en) An antiviral pharmaceutical composition
GB201304699D0 (en) Pharmaceutical compositions
PL3027062T3 (pl) Wyciąg drożdżowy
GB201321497D0 (en) Pharmaceutical compositions
GB201312851D0 (en) Pharmaceutical compositions
GB201304625D0 (en) New pharmaceutical composition